4

OWNERSHIP DOCUMENT

Company: CRESCENT BIOPHARMA, INC.
Filed: June 23, 2025
Period of Report: June 23, 2025
Accession Number: 0001104659-25-061817

View Document ↗ View on SEC.gov ↗